Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Jessica Borgers

Concepts (83)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Melanoma
8
2025
620
3.180
Why?
Cell- and Tissue-Based Therapy
3
2022
56
1.480
Why?
Lymphocytes, Tumor-Infiltrating
3
2024
111
1.210
Why?
Antigens, Neoplasm
2
2025
222
1.010
Why?
Neoplasms, Second Primary
2
2023
92
0.960
Why?
Seroconversion
1
2024
45
0.900
Why?
Myocarditis
1
2024
93
0.820
Why?
Immunotherapy, Adoptive
2
2022
184
0.800
Why?
Splenectomy
1
2020
51
0.670
Why?
Immune Tolerance
1
2021
321
0.660
Why?
Immunotherapy
1
2021
473
0.590
Why?
Autoantibodies
1
2024
1347
0.540
Why?
Skin Neoplasms
2
2024
754
0.540
Why?
Neoplasms
4
2023
2086
0.530
Why?
Cytokines
1
2020
1824
0.420
Why?
Interleukin-2
2
2024
413
0.370
Why?
Retrospective Studies
5
2024
12521
0.280
Why?
Programmed Cell Death 1 Receptor
2
2024
193
0.250
Why?
T-Lymphocytes
2
2025
1735
0.240
Why?
Aged, 80 and over
4
2024
6306
0.230
Why?
Tattooing
1
2024
11
0.230
Why?
Vaccines, DNA
1
2024
29
0.230
Why?
Aged
6
2025
18969
0.230
Why?
Humans
14
2025
114045
0.220
Why?
Cancer Vaccines
1
2024
137
0.210
Why?
Clinical Trials, Phase II as Topic
1
2022
59
0.210
Why?
Fecal Microbiota Transplantation
1
2022
13
0.210
Why?
Gastroenteritis
1
2023
65
0.210
Why?
Clinical Trials, Phase I as Topic
1
2022
45
0.210
Why?
Neoplasm Metastasis
1
2025
521
0.210
Why?
Antineoplastic Agents, Immunological
2
2023
152
0.200
Why?
Myeloid-Derived Suppressor Cells
1
2023
56
0.200
Why?
Survival Rate
2
2023
1638
0.200
Why?
Middle Aged
6
2025
26605
0.200
Why?
Life Support Care
1
2021
28
0.190
Why?
Precision Medicine
1
2025
335
0.190
Why?
Withholding Treatment
1
2021
66
0.190
Why?
Seasons
1
2023
440
0.180
Why?
Cell Engineering
1
2020
7
0.180
Why?
Neoplasm Staging
1
2024
1162
0.180
Why?
Feces
1
2022
372
0.180
Why?
Receptors, CCR
1
2020
7
0.170
Why?
Platelet Count
1
2020
79
0.170
Why?
Adult
5
2025
30375
0.170
Why?
Basophils
1
2020
64
0.170
Why?
Mortality
1
2021
283
0.170
Why?
Lymphocyte Subsets
1
2020
79
0.170
Why?
Leukocyte Count
1
2020
292
0.160
Why?
Female
7
2025
59324
0.160
Why?
Postoperative Period
1
2020
288
0.160
Why?
Genetic Therapy
1
2020
256
0.160
Why?
Pancreaticoduodenectomy
1
2020
132
0.160
Why?
Myeloid Cells
1
2020
126
0.160
Why?
Lymphocytes
1
2020
327
0.150
Why?
Randomized Controlled Trials as Topic
1
2022
1204
0.140
Why?
Monocytes
1
2020
503
0.140
Why?
Disease Progression
1
2024
2371
0.140
Why?
Receptors, Antigen, T-Cell
1
2020
615
0.140
Why?
Survival Analysis
1
2020
1206
0.140
Why?
Male
6
2025
55396
0.140
Why?
Hospitalization
1
2021
1762
0.100
Why?
Treatment Outcome
2
2024
9049
0.100
Why?
Pregnancy
1
2021
5499
0.090
Why?
Biomarkers
1
2020
3397
0.080
Why?
MART-1 Antigen
1
2024
10
0.060
Why?
Injections, Intradermal
1
2024
12
0.060
Why?
HLA-A2 Antigen
1
2024
35
0.060
Why?
Diarrhea, Infantile
1
2023
8
0.060
Why?
Failure to Thrive
1
2023
31
0.050
Why?
Enterocolitis
1
2023
33
0.050
Why?
Epitopes, T-Lymphocyte
1
2024
170
0.050
Why?
Ipilimumab
1
2022
27
0.050
Why?
Enteritis
1
2023
82
0.050
Why?
Tretinoin
1
2023
122
0.050
Why?
Netherlands
1
2021
64
0.050
Why?
Antibodies, Monoclonal, Humanized
1
2023
660
0.040
Why?
CD8-Positive T-Lymphocytes
1
2024
686
0.040
Why?
Vaccination
1
2024
1202
0.030
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2023
1356
0.030
Why?
Prognosis
1
2021
3315
0.030
Why?
Cohort Studies
1
2021
4883
0.020
Why?
Infant
1
2023
7943
0.020
Why?
Risk Factors
1
2021
8614
0.020
Why?
Borgers's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)